Yinghong Wang
Impact in
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
- Immunology top 2%
- Immune Cell Function and Interaction
Papers in
- Oncology 120
- Cancer Immunotherapy and Biomarkers 85
- Colorectal Cancer Treatments and Studies 28
- Neutropenia and Cancer Infections 12
- Pancreatic and Hepatic Oncology Research 12
- Epidemiology 42
- Microscopic Colitis 24
- Co-authors
- Hamzah Abu‐Sbeih (47 shared papers)Faisal S. Ali (20 shared papers)Wei Qiao (13 shared papers)Wenyi Luo (11 shared papers)Gottumukkala Subba Raju (15 shared papers)Anusha Shirwaikar Thomas (49 shared papers)David M. Richards (11 shared papers)Michael Lawrence Dougan (3 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (20 papers)The American Journal of Gastroenterology (13 papers)Journal of Cancer Research and Clinical Oncology (11 papers)Journal of the National Comprehensive Cancer Network (10 papers)Gastroenterology (10 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Yinghong Wang
245 papers receiving 12.6k citations
Yinghong Wang's Hit Papers
Peers
Comparison fields: 5 of 179
- Oncology 8.0k
- Immunology 1.6k
- Hepatology 501
- Genetics 572
- Pulmonary and Respiratory Medicine 1.6k
Countries citing papers authored by Yinghong Wang
This map shows the geographic impact of Yinghong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinghong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinghong Wang more than expected).
Fields of papers citing papers by Yinghong Wang
This network shows the impact of papers produced by Yinghong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinghong Wang. The network helps show where Yinghong Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yinghong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 263 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Hit paper breakdown → | 2018 | 2972 |
| 2 | Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group Hit paper breakdown → | 2017 | 1589 |
| 3 | Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis Hit paper breakdown → | 2018 | 616 |
| 4 | Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2019 | 469 |
| 5 | NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020 Hit paper breakdown → | 2020 | 411 |
| 6 | Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2022 | 334 |
| 7 | Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity Hit paper breakdown → | 2022 | 273 |
| 8 | 2006 | 235 | |
| 9 | 2020 | 207 | |
| 10 | 2018 | 206 | |
| 11 | 2018 | 201 | |
| 12 | 2018 | 181 | |
| 13 | 2020 | 169 | |
| 14 | 2018 | 166 | |
| 15 | 2019 | 165 | |
| 16 | 2018 | 159 | |
| 17 | 2019 | 159 | |
| 18 | 2019 | 158 | |
| 19 | 2020 | 146 | |
| 20 | 2006 | 133 |
About Yinghong Wang
Yinghong Wang is a scholar working on Oncology, Epidemiology, Hepatology, Infectious Diseases and Gastroenterology, having authored 263 papers that have together received 12.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (85 papers), Colorectal Cancer Treatments and Studies (28 papers), Microscopic Colitis (24 papers), Inflammatory Bowel Disease (12 papers), Neutropenia and Cancer Infections (12 papers), Pancreatic and Hepatic Oncology Research (12 papers), Clostridium difficile and Clostridium perfringens research (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). The work is most often cited by research in Oncology (8.0k citations), Immunology (1.6k citations), Hepatology (501 citations), Genetics (572 citations) and Pulmonary and Respiratory Medicine (1.6k citations). Yinghong Wang has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Hamzah Abu‐Sbeih, Faisal S. Ali, Wei Qiao, Wenyi Luo, Gottumukkala Subba Raju, Anusha Shirwaikar Thomas, David M. Richards, Michael Lawrence Dougan, Alberto Rubio‐Tapia and Mehmet Altan. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, The American Journal of Gastroenterology, Journal of Cancer Research and Clinical Oncology, Journal of the National Comprehensive Cancer Network and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.